Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rating Evaluations in Psoriatic Arthritis (PsA) With Enbrel

Trial Profile

Rating Evaluations in Psoriatic Arthritis (PsA) With Enbrel

Phase of Trial: Phase IV

Latest Information Update: 02 Jun 2015

At a glance

  • Drugs Etanercept (Primary)
  • Indications Psoriatic arthritis
  • Focus Therapeutic Use
  • Acronyms REPArE
  • Sponsors Amgen
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 17 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Nov 2007 Status change from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top